Download
s00391-021-01850-6.pdf 926,90KB
WeightNameValue
1000 Titel
  • Risikoidentifikation bei Polypharmazie in einer Pflegeheimpopulation
1000 Titelzusatz
  • Identification of polypharmacy-associated risks among nursing home residents
1000 Autor/in
  1. Specka, Michael |
  2. Groll, Maria |
  3. Scherbaum, Norbert |
  4. Wiltfang, Jens |
  5. Benninghoff, Jens |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-11
1000 Erschienen in
1000 Quellenangabe
  • 55(3):231-238
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00391-021-01850-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064868/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Introduction!#!Multimorbidity in old age is one reason for intensified pharmacotherapy. At the same time, an increase in medications could augment multimorbidity, especially when drug interactions leading to undesired drug effects occur.!##!Methods!#!In this cross-sectional study 918 mentally ill seniors living in nursing homes (mean age 79.3 (±11.6) years; 31.8% male) were included. Two different approaches to assess risks due to pharmacotherapy were applied: first mediQ, an online-based clinical decision support software (CDSS) and the PRISCUS list, which indicates potentially inappropriate medication. PRISCUS is the German equivalent to the American Geriatrics Society Beers criteria.!##!Results!#!Of the patients in the study 76.3% were at clinical risk, 2.2% at potentially high risk for drug interactions regarding the entire medication as tested by mediQ, and about 25% of the studied population received potentially inappropriate medication according to the PRISCUS list.!##!Conclusion!#!This difference clearly underlines the cumbersome complexity of identifying patients at risk by using these exemplary devices. The focus of avoiding undesired drug side effects should be taking medication only after thorough verification of clinical indications and under close monitoring. The CDSS or negative lists may support this process.
1000 Sacherschließung
lokal PRISCUS list
lokal Drug interaction
lokal Female [MeSH]
lokal Medikamentennebenwirkungen
lokal Multimorbidity
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal Inappropriate Prescribing/prevention
lokal Cross-Sectional Studies [MeSH]
lokal Drug side effects
lokal Multimorbidität
lokal Nursing Homes [MeSH]
lokal Medikamenteninteraktion
lokal PRISCUS-Liste
lokal Originalien
lokal Male [MeSH]
lokal Polypharmacy
lokal Polypharmacy [MeSH]
lokal Polypharmazie
lokal Potentially Inappropriate Medication List [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3BlY2thLCBNaWNoYWVs|https://frl.publisso.de/adhoc/uri/R3JvbGwsIE1hcmlh|https://frl.publisso.de/adhoc/uri/U2NoZXJiYXVtLCBOb3JiZXJ0|https://frl.publisso.de/adhoc/uri/V2lsdGZhbmcsIEplbnM=|https://frl.publisso.de/adhoc/uri/QmVubmluZ2hvZmYsIEplbnM=
1000 Hinweis
  • DeepGreen-ID: 6e2a25275a3b4d17ae5bbf625857ee15 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Risikoidentifikation bei Polypharmazie in einer Pflegeheimpopulation
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450951.rdf
1000 Erstellt am 2023-05-11T11:37:30.242+0200
1000 Erstellt von 322
1000 beschreibt frl:6450951
1000 Zuletzt bearbeitet Fri Oct 20 10:29:42 CEST 2023
1000 Objekt bearb. Fri Oct 20 10:29:42 CEST 2023
1000 Vgl. frl:6450951
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450951 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source